Filing metadata

Accession number
0001415889-25-019004
Form type
Form 4
Filer
Stoke Therapeutics, Inc.
CIK
CIK 1623526
Filed
Jul 02, 2025
Reporting period
Jul 01, 2025
Description
Insider transaction

Explore SEC Filings Hub